Triple GIP/GLP-1/glucagon agonist
Retatrutide
Also called LY3437943
Human-use stop
Retatrutide has no authorised public-use medicine in UK + USA. Do not treat a research listing as a care route.A research-only label, professional website, company registration or COA cannot turn it into an approved medicine.
Clinical-trial access only
Retatrutide is not an authorised medicine. A retail website claiming to sell it for personal use is not a legal care route.
MHRA enforcement noticeClinical-trial access only
Retatrutide remains investigational. No FDA-approved retail product exists.
A. Product statusClinical-trial access onlyTap for details
UK: Clinical-trial access only. Retatrutide is not an authorised medicine. A retail website claiming to sell it for personal use is not a legal care route. USA: Clinical-trial access only. Retatrutide remains investigational. No FDA-approved retail product exists.
B. Company and legal routeNo seller can turn this into an approved human-use routeTap for details
A real company, professional website, research-only disclaimer or laboratory report cannot override Gate A.
C. Exact purchaseDo not buy this for human self-useTap for details
A batch report cannot make an investigational, warned or unapproved product an approved consumer medicine.
Market surveillance: sites listing Retatrutide23 not recommendations
These records help identify risky listings. They are deliberately unranked and are not places PepCred recommends buying from.
Product name found in seller catalogue
Product name found in seller catalogue
Product name found in seller catalogue
Product name found in seller catalogue
Product name found in seller catalogue